What tirzepatide is made of — and why the ingredients matter

Picture the pen in your hand, what's actually inside it?

Say you've picked up a Mounjaro KwikPen for the first time and you're reading the leaflet. You see the word "tirzepatide" and, underneath, a list of ingredients that look like a chemistry exam. It's reasonable to wonder what any of it actually means for your body. The pen holds a clear, colourless solution. The active ingredient is tirzepatide itself; the rest of the listed components are excipients, pharmaceutical housekeeping chemicals whose job is to hold the peptide in the right pH, keep it stable at fridge temperature, and make the solution safe to inject. Specifically, tirzepatide's formulation uses a phosphate buffer to maintain pH, sodium chloride to match the solution's salt concentration to body fluids, and water for injections as the carrier. That's the complete list. There are no preservatives, no animal-derived proteins, and no insulin. If you want to confirm this for yourself in under a minute, the Mounjaro Summary of Product Characteristics on the Electronic Medicines Compendium (eMC) lists every ingredient alongside its function, a useful habit for anyone starting any new medicine.

The active peptide: why a synthetic amino-acid chain does two jobs at once

Tirzepatide's active molecule is a 39-amino-acid peptide, a short protein strand engineered to bind to two receptors in the body: the GIP receptor and the GLP-1 receptor. Both are involved in regulating appetite, blood-sugar levels, and how quickly the stomach empties after eating. Natural GIP and GLP-1 are hormones your gut releases after a meal; the problem is they break down in the bloodstream within minutes. Tirzepatide solves this by adding a C20 fatty-acid chain to the peptide's structure via a linker molecule, which allows it to bind loosely to albumin (a protein circulating in your blood). That attachment slows clearance dramatically, extending the medicine's action long enough for a single weekly injection to maintain consistent levels. Eli Lilly's chemists designed the molecule to activate both receptors simultaneously rather than separately, which is what makes it a dual GIP and GLP-1 receptor agonist and distinguishes it from older GLP-1-only medicines. The NHS tirzepatide medicine page explains how these combined mechanisms reduce appetite and support weight management for people with a clinical need.

How the peptide is manufactured, and why that matters for safety

Tirzepatide is produced using recombinant DNA technology: the genetic instructions for the peptide are inserted into bacterial or mammalian cells, which then synthesise it in controlled fermentation conditions. The resulting molecule is purified through multiple filtration and chromatography steps before being formulated into the injectable solution. This is the same class of manufacturing used for insulin analogues and many biological medicines. It means tirzepatide is not extracted from human or animal tissue, and it does not contain live cells or viral components. Every batch manufactured by Eli Lilly undergoes analytical testing for purity, potency and sterility before release. This rigorous process is part of why the manufacturing of tirzepatide is tightly regulated by medicines authorities, and why counterfeit versions (which have been seized in the UK) are genuinely dangerous: they can contain wrong concentrations, impurities, or entirely different substances. If you're curious about the specific components that go into the molecule, our page on what tirzepatide is made from walks through the building blocks in plain language, and you can find similar detail about the pen itself on our page covering what Mounjaro is made of. Understanding what the genuine medicine is made of gives you a baseline for questioning anything that deviates from it.

What the ingredients tell you about eligibility and clinical assessment

Knowing that tirzepatide is a synthetic peptide medicine helps explain two things that patients sometimes find confusing. First, because it is not a small-molecule drug but a larger biological structure, oral absorption is poor, which is why it's injected rather than swallowed (oral semaglutide takes a different approach using an absorption enhancer). Second, because the molecule works on hormone-receptor pathways, its effects depend on an individual's existing physiology: the same dose can behave differently in someone with type 2 diabetes compared to someone without it. That's a core reason why tirzepatide is a prescription-only medicine requiring individual clinical assessment, not an over-the-counter supplement. A prescriber reviews your health history, current medicines, and BMI before determining whether it is appropriate and at which starting strength. If you'd like to explore whether treatment could be suitable for you, you can read more about the clinical consultation process at nume or look at the broader weight-loss treatment options we review. For anyone considering treatment, our clinical team is available to answer questions specific to your situation. Every consultation at nume is reviewed by a GPhC-registered prescriber, a real clinician reads your answers on the same day you submit them.